Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00626990 · OUTCOME

Quality of Life of the Patient

Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) · Source last updated 2023-09-11

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
from 14 days prior to randomization till five years or death (time till death is up to 10.9 years after patient enrollment in the study)

What was measured

Quality of life was assessed by the EORTC Quality of Life Questionnaire (QLQ-C30) version 3 and the Brain Cancer Module-20

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2025-04
denom Units Selected
Participants
description
Quality of life was assessed by the EORTC Quality of Life Questionnaire (QLQ-C30) version 3 and the Brain Cancer Module-20
reporting Status
NOT_POSTED
time Frame
from 14 days prior to randomization till five years or death (time till death is up to 10.9 years after patient enrollment in the study)
title
Quality of Life of the Patient
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice